WHO-evaluated AI solutions to support clinicians in making quick and accurate diagnosis and treatment decisions. This provides global access to Tuberculosis, Silicosis, and Pediatric Tuberculosis care and real-time disease surveillance.
World’s
Most Adopted
Healthcare AI
25M+
Lives impacted
to date
90+
Countries via 3100+ sites
1B+
Training datasets
Transforming Healthcare Pathways with AI
Accelerating Early Detection & Management of Lung Cancer
The end-to-end Lung Cancer care continuum detects lung nodules early, measures for disease progression and manages cases to support clinicians, improving outcomes for patients. It also helps advance developments for lung health in the pharmaceutical industry.
Enabling Timely Intervention in Stroke Care
An AI-powered care coordination suite to enable patient triage, ensuring seamless clinical coordination with real-time communication. It supports Hub & Spoke networks to facilitate timely stroke interventions by clinicians, anywhere.
The Global Impact of AI: Real Stories,
Real Lives Transformed
From Aims to Achievements: Fulfilling Clinical & Business Goals
Explore Our Latest Developments
AI Helps Doctors Treat Stroke Faster: Qure.ai Study Reveals Significant Real-World Impact
Read StudyJusty Antony Chiramal , Jacob Johnson, Jemin Webster, D. Rachel Nag, Dennis Robert, Tamaghna Ghosh, Satish Golla, Saniya Pawar, Pranav Krishnan, Paul K. Drain, Stephen J. Mooney
“As part of the EDISON Alliance’s 1 Billion Lives Challenge, AstraZeneca, along with Qure.ai, will be screening 5 million patients by 2025. We look forward to deepening collaboration to accelerate scalable and affordable digital solutions to help improve access to healthcare and transform patient outcomes, especially in underserved communities.”
Leif Johannsson
Chairman at AstraZeneca
“We are thrilled to collaborate with Qure.ai to support surgeons in diagnosing and treating stroke by enabling quicker decision-making, streamlining data sharing between two hospitals, and improving efficiencies so that more stroke patients in India can be treated within the critical time window."
Michael Blackwell
President and Managing Director at Medtronic India
“AI has the potential to power the early diagnosis of lung cancer, TB or Stroke giving the best chance of survival outcomes and improving quality of life for patients. Initial real-world studies and recent FDA clearances have provided compelling evidence for the potential of Qure.ai’s medical imaging AI innovations.”
David M. Rubin
Managing Director at Merck Global Health Innovation Fund LLC
”Qure’s AI technology fits in all kinds of machines, new or old, making sure that we can use the old hardware and save our resources. By integrating Qure.ai with our existing X-ray systems, we can now screen patients promptly, obtain immediate results, and promptly refer clients for further investigation, ensuring timely management of TB cases.”
Llang Bridget M. Maama-Maime
National TB Programme Manager at Ministry of Health, Lesotho
“AI solutions such as qXR should improve the pathway logistics by flagging abnormalities on chest X-rays as soon as they are undertaken, helping patients progress rapidly to CT scanning.”
Prof. David Baldwin
Respiratory Consultant at Nottingham University Hospitals NHS Trust & Honorary Professor of Medicine at the University of Nottingham
“We definitely need to have a quick movement on children. I think children are always left a bit behind. So, it's so exciting that Qure is really looking into and trying to find a way to include the children in the screening with modern digital platforms.”
Dr. Seraphine Kaminsa
Senior Technical Tuberculosis Advisor at Save The Children US
“Lung cancer detection is a significant challenge for healthcare systems globally, with nearly 50% of patients diagnosed at stage 4, leading to poorer outcomes. By using Qure’s AI solution to enhance the speed and accuracy of chest X-rays performed annually at NHSGGC, we can expedite further imaging and treatment, improving patient care throughout the pathway.”
Prof. David Lowe
Professor of Health Innovation at University of Glasgow
"In strategic partnership with Qure.ai, Medica Group is pioneering the integration of augmented intelligence into healthcare, improving patient outcomes by supporting clinicians with cutting edge tools to enhance diagnostic accuracy."
Andrew Cannon
Chief Executive Officer at Medica Group
“As part of the EDISON Alliance’s 1 Billion Lives Challenge, AstraZeneca, along with Qure.ai, will be screening 5 million patients by 2025. We look forward to deepening collaboration to accelerate scalable and affordable digital solutions to help improve access to healthcare and transform patient outcomes, especially in underserved communities.”
Leif Johannsson
Chairman at AstraZeneca
“We are thrilled to collaborate with Qure.ai to support surgeons in diagnosing and treating stroke by enabling quicker decision-making, streamlining data sharing between two hospitals, and improving efficiencies so that more stroke patients in India can be treated within the critical time window."
Michael Blackwell
President and Managing Director at Medtronic India
“AI has the potential to power the early diagnosis of lung cancer, TB or Stroke giving the best chance of survival outcomes and improving quality of life for patients. Initial real-world studies and recent FDA clearances have provided compelling evidence for the potential of Qure.ai’s medical imaging AI innovations.”
David M. Rubin
Managing Director at Merck Global Health Innovation Fund LLC
”Qure’s AI technology fits in all kinds of machines, new or old, making sure that we can use the old hardware and save our resources. By integrating Qure.ai with our existing X-ray systems, we can now screen patients promptly, obtain immediate results, and promptly refer clients for further investigation, ensuring timely management of TB cases.”
Llang Bridget M. Maama-Maime
National TB Programme Manager at Ministry of Health, Lesotho
“AI solutions such as qXR should improve the pathway logistics by flagging abnormalities on chest X-rays as soon as they are undertaken, helping patients progress rapidly to CT scanning.”
Prof. David Baldwin
Respiratory Consultant at Nottingham University Hospitals NHS Trust & Honorary Professor of Medicine at the University of Nottingham
“We definitely need to have a quick movement on children. I think children are always left a bit behind. So, it's so exciting that Qure is really looking into and trying to find a way to include the children in the screening with modern digital platforms.”
Dr. Seraphine Kaminsa
Senior Technical Tuberculosis Advisor at Save The Children US
“Lung cancer detection is a significant challenge for healthcare systems globally, with nearly 50% of patients diagnosed at stage 4, leading to poorer outcomes. By using Qure’s AI solution to enhance the speed and accuracy of chest X-rays performed annually at NHSGGC, we can expedite further imaging and treatment, improving patient care throughout the pathway.”
Prof. David Lowe
Professor of Health Innovation at University of Glasgow
"In strategic partnership with Qure.ai, Medica Group is pioneering the integration of augmented intelligence into healthcare, improving patient outcomes by supporting clinicians with cutting edge tools to enhance diagnostic accuracy."
Andrew Cannon
Chief Executive Officer at Medica Group
“As part of the EDISON Alliance’s 1 Billion Lives Challenge, AstraZeneca, along with Qure.ai, will be screening 5 million patients by 2025. We look forward to deepening collaboration to accelerate scalable and affordable digital solutions to help improve access to healthcare and transform patient outcomes, especially in underserved communities.”
Leif Johannsson
Chairman at AstraZeneca
“We are thrilled to collaborate with Qure.ai to support surgeons in diagnosing and treating stroke by enabling quicker decision-making, streamlining data sharing between two hospitals, and improving efficiencies so that more stroke patients in India can be treated within the critical time window."
Michael Blackwell
President and Managing Director at Medtronic India
“AI has the potential to power the early diagnosis of lung cancer, TB or Stroke giving the best chance of survival outcomes and improving quality of life for patients. Initial real-world studies and recent FDA clearances have provided compelling evidence for the potential of Qure.ai’s medical imaging AI innovations.”
David M. Rubin
Managing Director at Merck Global Health Innovation Fund LLC
”Qure’s AI technology fits in all kinds of machines, new or old, making sure that we can use the old hardware and save our resources. By integrating Qure.ai with our existing X-ray systems, we can now screen patients promptly, obtain immediate results, and promptly refer clients for further investigation, ensuring timely management of TB cases.”
Llang Bridget M. Maama-Maime
National TB Programme Manager at Ministry of Health, Lesotho
“AI solutions such as qXR should improve the pathway logistics by flagging abnormalities on chest X-rays as soon as they are undertaken, helping patients progress rapidly to CT scanning.”
Prof. David Baldwin
Respiratory Consultant at Nottingham University Hospitals NHS Trust & Honorary Professor of Medicine at the University of Nottingham
“We definitely need to have a quick movement on children. I think children are always left a bit behind. So, it's so exciting that Qure is really looking into and trying to find a way to include the children in the screening with modern digital platforms.”
Dr. Seraphine Kaminsa
Senior Technical Tuberculosis Advisor at Save The Children US
“Lung cancer detection is a significant challenge for healthcare systems globally, with nearly 50% of patients diagnosed at stage 4, leading to poorer outcomes. By using Qure’s AI solution to enhance the speed and accuracy of chest X-rays performed annually at NHSGGC, we can expedite further imaging and treatment, improving patient care throughout the pathway.”
Prof. David Lowe
Professor of Health Innovation at University of Glasgow
"In strategic partnership with Qure.ai, Medica Group is pioneering the integration of augmented intelligence into healthcare, improving patient outcomes by supporting clinicians with cutting edge tools to enhance diagnostic accuracy."
Andrew Cannon
Chief Executive Officer at Medica Group
“As part of the EDISON Alliance’s 1 Billion Lives Challenge, AstraZeneca, along with Qure.ai, will be screening 5 million patients by 2025. We look forward to deepening collaboration to accelerate scalable and affordable digital solutions to help improve access to healthcare and transform patient outcomes, especially in underserved communities.”
Leif Johannsson
Chairman at AstraZeneca
“We are thrilled to collaborate with Qure.ai to support surgeons in diagnosing and treating stroke by enabling quicker decision-making, streamlining data sharing between two hospitals, and improving efficiencies so that more stroke patients in India can be treated within the critical time window."
Michael Blackwell
President and Managing Director at Medtronic India
“AI has the potential to power the early diagnosis of lung cancer, TB or Stroke giving the best chance of survival outcomes and improving quality of life for patients. Initial real-world studies and recent FDA clearances have provided compelling evidence for the potential of Qure.ai’s medical imaging AI innovations.”
David M. Rubin
Managing Director at Merck Global Health Innovation Fund LLC
”Qure’s AI technology fits in all kinds of machines, new or old, making sure that we can use the old hardware and save our resources. By integrating Qure.ai with our existing X-ray systems, we can now screen patients promptly, obtain immediate results, and promptly refer clients for further investigation, ensuring timely management of TB cases.”
Llang Bridget M. Maama-Maime
National TB Programme Manager at Ministry of Health, Lesotho
“AI solutions such as qXR should improve the pathway logistics by flagging abnormalities on chest X-rays as soon as they are undertaken, helping patients progress rapidly to CT scanning.”
Prof. David Baldwin
Respiratory Consultant at Nottingham University Hospitals NHS Trust & Honorary Professor of Medicine at the University of Nottingham
“We definitely need to have a quick movement on children. I think children are always left a bit behind. So, it's so exciting that Qure is really looking into and trying to find a way to include the children in the screening with modern digital platforms.”
Dr. Seraphine Kaminsa
Senior Technical Tuberculosis Advisor at Save The Children US
“Lung cancer detection is a significant challenge for healthcare systems globally, with nearly 50% of patients diagnosed at stage 4, leading to poorer outcomes. By using Qure’s AI solution to enhance the speed and accuracy of chest X-rays performed annually at NHSGGC, we can expedite further imaging and treatment, improving patient care throughout the pathway.”
Prof. David Lowe
Professor of Health Innovation at University of Glasgow
"In strategic partnership with Qure.ai, Medica Group is pioneering the integration of augmented intelligence into healthcare, improving patient outcomes by supporting clinicians with cutting edge tools to enhance diagnostic accuracy."
Andrew Cannon
Chief Executive Officer at Medica Group
“As part of the EDISON Alliance’s 1 Billion Lives Challenge, AstraZeneca, along with Qure.ai, will be screening 5 million patients by 2025. We look forward to deepening collaboration to accelerate scalable and affordable digital solutions to help improve access to healthcare and transform patient outcomes, especially in underserved communities.”
Leif Johannsson
Chairman at AstraZeneca
“We are thrilled to collaborate with Qure.ai to support surgeons in diagnosing and treating stroke by enabling quicker decision-making, streamlining data sharing between two hospitals, and improving efficiencies so that more stroke patients in India can be treated within the critical time window."
Michael Blackwell
President and Managing Director at Medtronic India
“AI has the potential to power the early diagnosis of lung cancer, TB or Stroke giving the best chance of survival outcomes and improving quality of life for patients. Initial real-world studies and recent FDA clearances have provided compelling evidence for the potential of Qure.ai’s medical imaging AI innovations.”
David M. Rubin
Managing Director at Merck Global Health Innovation Fund LLC
”Qure’s AI technology fits in all kinds of machines, new or old, making sure that we can use the old hardware and save our resources. By integrating Qure.ai with our existing X-ray systems, we can now screen patients promptly, obtain immediate results, and promptly refer clients for further investigation, ensuring timely management of TB cases.”
Llang Bridget M. Maama-Maime
National TB Programme Manager at Ministry of Health, Lesotho
“AI solutions such as qXR should improve the pathway logistics by flagging abnormalities on chest X-rays as soon as they are undertaken, helping patients progress rapidly to CT scanning.”
Prof. David Baldwin
Respiratory Consultant at Nottingham University Hospitals NHS Trust & Honorary Professor of Medicine at the University of Nottingham
“We definitely need to have a quick movement on children. I think children are always left a bit behind. So, it's so exciting that Qure is really looking into and trying to find a way to include the children in the screening with modern digital platforms.”
Dr. Seraphine Kaminsa
Senior Technical Tuberculosis Advisor at Save The Children US
“Lung cancer detection is a significant challenge for healthcare systems globally, with nearly 50% of patients diagnosed at stage 4, leading to poorer outcomes. By using Qure’s AI solution to enhance the speed and accuracy of chest X-rays performed annually at NHSGGC, we can expedite further imaging and treatment, improving patient care throughout the pathway.”
Prof. David Lowe
Professor of Health Innovation at University of Glasgow
"In strategic partnership with Qure.ai, Medica Group is pioneering the integration of augmented intelligence into healthcare, improving patient outcomes by supporting clinicians with cutting edge tools to enhance diagnostic accuracy."
Andrew Cannon
Chief Executive Officer at Medica Group
“As part of the EDISON Alliance’s 1 Billion Lives Challenge, AstraZeneca, along with Qure.ai, will be screening 5 million patients by 2025. We look forward to deepening collaboration to accelerate scalable and affordable digital solutions to help improve access to healthcare and transform patient outcomes, especially in underserved communities.”
Leif Johannsson
Chairman at AstraZeneca
“We are thrilled to collaborate with Qure.ai to support surgeons in diagnosing and treating stroke by enabling quicker decision-making, streamlining data sharing between two hospitals, and improving efficiencies so that more stroke patients in India can be treated within the critical time window."
Michael Blackwell
President and Managing Director at Medtronic India
“AI has the potential to power the early diagnosis of lung cancer, TB or Stroke giving the best chance of survival outcomes and improving quality of life for patients. Initial real-world studies and recent FDA clearances have provided compelling evidence for the potential of Qure.ai’s medical imaging AI innovations.”
David M. Rubin
Managing Director at Merck Global Health Innovation Fund LLC
”Qure’s AI technology fits in all kinds of machines, new or old, making sure that we can use the old hardware and save our resources. By integrating Qure.ai with our existing X-ray systems, we can now screen patients promptly, obtain immediate results, and promptly refer clients for further investigation, ensuring timely management of TB cases.”
Llang Bridget M. Maama-Maime
National TB Programme Manager at Ministry of Health, Lesotho
“AI solutions such as qXR should improve the pathway logistics by flagging abnormalities on chest X-rays as soon as they are undertaken, helping patients progress rapidly to CT scanning.”
Prof. David Baldwin
Respiratory Consultant at Nottingham University Hospitals NHS Trust & Honorary Professor of Medicine at the University of Nottingham
“We definitely need to have a quick movement on children. I think children are always left a bit behind. So, it's so exciting that Qure is really looking into and trying to find a way to include the children in the screening with modern digital platforms.”
Dr. Seraphine Kaminsa
Senior Technical Tuberculosis Advisor at Save The Children US
“Lung cancer detection is a significant challenge for healthcare systems globally, with nearly 50% of patients diagnosed at stage 4, leading to poorer outcomes. By using Qure’s AI solution to enhance the speed and accuracy of chest X-rays performed annually at NHSGGC, we can expedite further imaging and treatment, improving patient care throughout the pathway.”
Prof. David Lowe
Professor of Health Innovation at University of Glasgow
"In strategic partnership with Qure.ai, Medica Group is pioneering the integration of augmented intelligence into healthcare, improving patient outcomes by supporting clinicians with cutting edge tools to enhance diagnostic accuracy."
Andrew Cannon
Chief Executive Officer at Medica Group
“As part of the EDISON Alliance’s 1 Billion Lives Challenge, AstraZeneca, along with Qure.ai, will be screening 5 million patients by 2025. We look forward to deepening collaboration to accelerate scalable and affordable digital solutions to help improve access to healthcare and transform patient outcomes, especially in underserved communities.”
Leif Johannsson
Chairman at AstraZeneca
“We are thrilled to collaborate with Qure.ai to support surgeons in diagnosing and treating stroke by enabling quicker decision-making, streamlining data sharing between two hospitals, and improving efficiencies so that more stroke patients in India can be treated within the critical time window."
Michael Blackwell
President and Managing Director at Medtronic India
“AI has the potential to power the early diagnosis of lung cancer, TB or Stroke giving the best chance of survival outcomes and improving quality of life for patients. Initial real-world studies and recent FDA clearances have provided compelling evidence for the potential of Qure.ai’s medical imaging AI innovations.”
David M. Rubin
Managing Director at Merck Global Health Innovation Fund LLC
”Qure’s AI technology fits in all kinds of machines, new or old, making sure that we can use the old hardware and save our resources. By integrating Qure.ai with our existing X-ray systems, we can now screen patients promptly, obtain immediate results, and promptly refer clients for further investigation, ensuring timely management of TB cases.”
Llang Bridget M. Maama-Maime
National TB Programme Manager at Ministry of Health, Lesotho
“AI solutions such as qXR should improve the pathway logistics by flagging abnormalities on chest X-rays as soon as they are undertaken, helping patients progress rapidly to CT scanning.”
Prof. David Baldwin
Respiratory Consultant at Nottingham University Hospitals NHS Trust & Honorary Professor of Medicine at the University of Nottingham
“We definitely need to have a quick movement on children. I think children are always left a bit behind. So, it's so exciting that Qure is really looking into and trying to find a way to include the children in the screening with modern digital platforms.”
Dr. Seraphine Kaminsa
Senior Technical Tuberculosis Advisor at Save The Children US
“Lung cancer detection is a significant challenge for healthcare systems globally, with nearly 50% of patients diagnosed at stage 4, leading to poorer outcomes. By using Qure’s AI solution to enhance the speed and accuracy of chest X-rays performed annually at NHSGGC, we can expedite further imaging and treatment, improving patient care throughout the pathway.”
Prof. David Lowe
Professor of Health Innovation at University of Glasgow
"In strategic partnership with Qure.ai, Medica Group is pioneering the integration of augmented intelligence into healthcare, improving patient outcomes by supporting clinicians with cutting edge tools to enhance diagnostic accuracy."
Andrew Cannon
Chief Executive Officer at Medica Group
qTrack
AI-powered reporting and seamless collaboration platform offers an end-to-end solution for screening programs and case management. qTrack enables enhanced care coordination and monitors program health developments through customized dashboards.
